Cargando…

Objective secondhand smoke exposure in chronic obstructive pulmonary disease patients without active smoking: the U.S. National Health and Nutrition Examination Survey (NHANES) 2007–2012

BACKGROUND: Secondhand smoke (SHS) may be related to worse outcomes in chronic obstructive pulmonary disease (COPD), but the reported SHS prevalence in different studies varied from 27% to 65% and the effects of SHS are still questionable among these patients. The study aims were to estimate the obj...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Zhen, Jiang, Hongwei, Xu, Zhongyu, Li, Hongyu, Wu, Nanjin, Yin, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210150/
https://www.ncbi.nlm.nih.gov/pubmed/32395489
http://dx.doi.org/10.21037/atm.2020.03.145
_version_ 1783531222099558400
author Fu, Zhen
Jiang, Hongwei
Xu, Zhongyu
Li, Hongyu
Wu, Nanjin
Yin, Ping
author_facet Fu, Zhen
Jiang, Hongwei
Xu, Zhongyu
Li, Hongyu
Wu, Nanjin
Yin, Ping
author_sort Fu, Zhen
collection PubMed
description BACKGROUND: Secondhand smoke (SHS) may be related to worse outcomes in chronic obstructive pulmonary disease (COPD), but the reported SHS prevalence in different studies varied from 27% to 65% and the effects of SHS are still questionable among these patients. The study aims were to estimate the objective SHS prevalence and explore the SHS impact on outcomes among COPD patients without active smoking. METHODS: A cross-sectional design combined with longitudinal death outcome. We selected COPD patients over 40 years old based on the spirometry from National Health and Nutrition Examination Survey (2007–2012), and used the tobacco-specific biomarkers [cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonol] to determine exposure statuses (active smoking, SHS exposure, or no smoke exposure). Then we estimated the short-term (past 2–4 days) and medium-term (past 6–12 weeks) SHS prevalence among 334 patients without active smoking. Weighted multiple regressions were performed to assess the associations between medium-term SHS exposure and outcomes (symptoms, health status, medical institution visits, and death). RESULTS: Among the patients without active smoking, the objective prevalence rates of short-term and medium-term SHS were 66.65% [95% confidence interval (CI), 59.63–73.67%] and 34.91% (95% CI, 28.86%–40.96%), respectively. Medium-term SHS exposure showed a significant effect (odds ratio, 3.57; 95% CI, 1.22–10.40) on more chronic coughing after adjusting for the covariates and indicated a trend of unadjusted increasing death risk (log-rank test, P=0.01). CONCLUSIONS: Among COPD patients without active smoking, both short-term and medium-term SHS exposure are prevalent. Chronic cough may be the most susceptible patient-centred outcome related to medium-term SHS exposure. The crude longitudinal trend of elevated death risk associated with medium-term SHS exposure deserves further study.
format Online
Article
Text
id pubmed-7210150
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-72101502020-05-11 Objective secondhand smoke exposure in chronic obstructive pulmonary disease patients without active smoking: the U.S. National Health and Nutrition Examination Survey (NHANES) 2007–2012 Fu, Zhen Jiang, Hongwei Xu, Zhongyu Li, Hongyu Wu, Nanjin Yin, Ping Ann Transl Med Original Article BACKGROUND: Secondhand smoke (SHS) may be related to worse outcomes in chronic obstructive pulmonary disease (COPD), but the reported SHS prevalence in different studies varied from 27% to 65% and the effects of SHS are still questionable among these patients. The study aims were to estimate the objective SHS prevalence and explore the SHS impact on outcomes among COPD patients without active smoking. METHODS: A cross-sectional design combined with longitudinal death outcome. We selected COPD patients over 40 years old based on the spirometry from National Health and Nutrition Examination Survey (2007–2012), and used the tobacco-specific biomarkers [cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonol] to determine exposure statuses (active smoking, SHS exposure, or no smoke exposure). Then we estimated the short-term (past 2–4 days) and medium-term (past 6–12 weeks) SHS prevalence among 334 patients without active smoking. Weighted multiple regressions were performed to assess the associations between medium-term SHS exposure and outcomes (symptoms, health status, medical institution visits, and death). RESULTS: Among the patients without active smoking, the objective prevalence rates of short-term and medium-term SHS were 66.65% [95% confidence interval (CI), 59.63–73.67%] and 34.91% (95% CI, 28.86%–40.96%), respectively. Medium-term SHS exposure showed a significant effect (odds ratio, 3.57; 95% CI, 1.22–10.40) on more chronic coughing after adjusting for the covariates and indicated a trend of unadjusted increasing death risk (log-rank test, P=0.01). CONCLUSIONS: Among COPD patients without active smoking, both short-term and medium-term SHS exposure are prevalent. Chronic cough may be the most susceptible patient-centred outcome related to medium-term SHS exposure. The crude longitudinal trend of elevated death risk associated with medium-term SHS exposure deserves further study. AME Publishing Company 2020-04 /pmc/articles/PMC7210150/ /pubmed/32395489 http://dx.doi.org/10.21037/atm.2020.03.145 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Fu, Zhen
Jiang, Hongwei
Xu, Zhongyu
Li, Hongyu
Wu, Nanjin
Yin, Ping
Objective secondhand smoke exposure in chronic obstructive pulmonary disease patients without active smoking: the U.S. National Health and Nutrition Examination Survey (NHANES) 2007–2012
title Objective secondhand smoke exposure in chronic obstructive pulmonary disease patients without active smoking: the U.S. National Health and Nutrition Examination Survey (NHANES) 2007–2012
title_full Objective secondhand smoke exposure in chronic obstructive pulmonary disease patients without active smoking: the U.S. National Health and Nutrition Examination Survey (NHANES) 2007–2012
title_fullStr Objective secondhand smoke exposure in chronic obstructive pulmonary disease patients without active smoking: the U.S. National Health and Nutrition Examination Survey (NHANES) 2007–2012
title_full_unstemmed Objective secondhand smoke exposure in chronic obstructive pulmonary disease patients without active smoking: the U.S. National Health and Nutrition Examination Survey (NHANES) 2007–2012
title_short Objective secondhand smoke exposure in chronic obstructive pulmonary disease patients without active smoking: the U.S. National Health and Nutrition Examination Survey (NHANES) 2007–2012
title_sort objective secondhand smoke exposure in chronic obstructive pulmonary disease patients without active smoking: the u.s. national health and nutrition examination survey (nhanes) 2007–2012
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210150/
https://www.ncbi.nlm.nih.gov/pubmed/32395489
http://dx.doi.org/10.21037/atm.2020.03.145
work_keys_str_mv AT fuzhen objectivesecondhandsmokeexposureinchronicobstructivepulmonarydiseasepatientswithoutactivesmokingtheusnationalhealthandnutritionexaminationsurveynhanes20072012
AT jianghongwei objectivesecondhandsmokeexposureinchronicobstructivepulmonarydiseasepatientswithoutactivesmokingtheusnationalhealthandnutritionexaminationsurveynhanes20072012
AT xuzhongyu objectivesecondhandsmokeexposureinchronicobstructivepulmonarydiseasepatientswithoutactivesmokingtheusnationalhealthandnutritionexaminationsurveynhanes20072012
AT lihongyu objectivesecondhandsmokeexposureinchronicobstructivepulmonarydiseasepatientswithoutactivesmokingtheusnationalhealthandnutritionexaminationsurveynhanes20072012
AT wunanjin objectivesecondhandsmokeexposureinchronicobstructivepulmonarydiseasepatientswithoutactivesmokingtheusnationalhealthandnutritionexaminationsurveynhanes20072012
AT yinping objectivesecondhandsmokeexposureinchronicobstructivepulmonarydiseasepatientswithoutactivesmokingtheusnationalhealthandnutritionexaminationsurveynhanes20072012